HLB Therapeutics Co.,Ltd.
115450
Rank in Stocks
#18248
HLB Therapeutics Co.,Ltd. operates as a biotechnology company, focusing on the... HLB Therapeutics Co.,Ltd. operates as a biotechnology company, focusing on the creation of pharmaceutical products for both the South Korean and international markets. A significant part of its research and development initiatives includes GBT-201, a compound utilizing Thymosin beta designed to treat various eye ailments such as dry eye syndrome and neurotrophic keratopathy. Additionally, the company is advancing OKN-007 as a potential therapy for glioblastoma brain tumors. Beyond its pharmaceutical endeavors, HLB Therapeutics is also involved in the wholesale distribution of vaccines and the production of electrical and electronic components like motors, pumps, and transformers. The company, which established its roots in 2000 and is based in Seongnam, South Korea, underwent a name change in December 2021, transitioning from its former identity as G-treeBNT Co., Ltd. to its current designation.
Share Price
$2.02
Market Cap
$190.66M
Change (1 day)
7.96%
Change (1 year)
-1.16%
Country
KR
Trade HLB Therapeutics Co.,Ltd. (115450)
Category
Healthcare
Stock price history for HLB Therapeutics Co.,Ltd. (115450)
Highest end of day price: $1.94 on 2026-10-01
Lowest end of day price: $9.82 on 2010-03-01
Lowest end of day price: $9.82 on 2010-03-01
Stock price history of HLB Therapeutics Co.,Ltd. from 2010 to 2026
Annual Stock Price Performance
| Year | Performance |
|---|---|
| 2026 (TTM) | -4.53% |
| 2025 | -69.48% |
| 2024 | 142.67% |
| 2023 | -24.36% |
| 2022 | -34.28% |
| 2021 | -50.71% |
| 2020 | 1.61% |
| 2019 | 7.70% |
| 2018 | -17.13% |
| 2017 | 106.04% |
| 2016 | 24.88% |
| 2015 | 254.54% |
| 2014 | 20.37% |
| 2013 | -14.85% |
| 2012 | -28.46% |
| 2011 | -62.15% |
| 2010 | 0.00% |
Stock price for similar companies or competitors
| Company | Stock price | Change 1y% | Country |
|---|---|---|---|
| $536.13 | 25.72% |
US
|
|
| $200.12 | 645.31% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $291.76 | 2.51% |
BE
|
|
| $880.01 | 8.09% |
NL
|
